Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis

被引:153
作者
Ryu, O. H.
Atkinson, J. C.
Hoehn, G. T.
Illei, G. G.
Hart, T. C.
机构
[1] NIDCR, Human Craniofacial Genet Sect, NIH, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA
[2] NIDCR, Clin Res Core, NIH, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA
[3] NIDCR, Sjogrens Syndrome Clin, NIH, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA
[4] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA
关键词
Sjogren's syndrome; saliva; proteomics; 2D-DIGE; SELDI-TOF-MS;
D O I
10.1093/rheumatology/kei212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To identify the most significant salivary biomarkers in Sjogren's syndrome (SS) using proteomic methods. Methods. Parotid saliva from 20 non-SS subjects and 41 primary SS patients was analysed. Protein expression profiles for each sample were generated by surface-enhanced laser desorption/ionization time-of-flight-mass spectrometry (SELDI-TOF-MS). Mean peak intensities of SS patients and non-SS subjects were compared by univariate analyses. Samples pooled by diagnosis (SS and non-SS) and labelled with different Cy dyes were compared by two-dimensional difference gel electrophoresis (2D-DIGE). Two protein levels that were most significantly different by SELDI-TOF-MS and 2D-DIGE were validated by enzyme-linked immunosorbent assay in individual samples. Results. SELDI-TOF-MS of 10-200 kDa peaks revealed eight peaks with > 2-fold changes in the SS group that differed from non-SS at P < 0.005. Peaks of 11.8, 12.0, 14.3, 80.6 and 83.7 kDa were increased, while 17.3, 25.4, and 35.4 kDa peaks were decreased in SS samples. 2D-DIGE identified significant increases of beta-2-microglobulin, lactoferrin, immunoglobulin (Ig) kappa light chain, polymeric Ig receptor, lysozyme C and cystatin C in all stages of SS. Two presumed proline-rich proteins, amylase and carbonic anhydrase VI, were reduced in the patient group. Three of these ten biomarkers have not been associated previously with SS. Conclusions. The salivary proteomic profile of SS is a mixture of increased inflammatory proteins and decreased acinar proteins when compared with non-SS. Future studies will test the ability of these biomarker levels, alone and in combination, to diagnose the salivary component of SS.
引用
收藏
页码:1077 / 1086
页数:10
相关论文
共 54 条
  • [1] Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins
    Almståhl, A
    Wikström, M
    Groenink, J
    [J]. ORAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 16 (06): : 345 - 352
  • [2] SERUM ANTI-SS-B/LA AND IGA RHEUMATOID-FACTOR ARE MARKERS OF SALIVARY-GLAND DISEASE-ACTIVITY IN PRIMARY SJOGRENS-SYNDROME
    ATKINSON, JC
    TRAVIS, WD
    SLOCUM, L
    EBBS, WL
    FOX, PC
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (11): : 1368 - 1372
  • [3] 2-DIMENSIONAL ELECTROPHORESIS OF HUMAN PAROTID SALIVARY PROTEINS FROM NORMAL AND CONNECTIVE-TISSUE DISORDER SUBJECTS USING IMMOBILIZED PH GRADIENTS
    BEELEY, JA
    KHOO, KS
    LAMEY, PJ
    [J]. ELECTROPHORESIS, 1991, 12 (7-8) : 493 - 499
  • [4] Beeley JA, 1999, ELECTROPHORESIS, V20, P1652, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1652::AID-ELPS1652>3.0.CO
  • [5] 2-R
  • [6] SIALOCHEMICAL STUDY ON PATIENTS WITH SJOGRENS SYNDROME
    BENEDEKSPAT, E
    BERENYI, B
    CSIBA, A
    [J]. ARCHIVES OF ORAL BIOLOGY, 1975, 20 (10) : 649 - 652
  • [7] THE DIAGNOSIS VALUE OF BETA-2-MICROGLOBULIN AND IMMUNOGLOBULINS IN PRIMARY SJOGRENS-SYNDROME
    BONGI, SM
    CAMPANA, G
    DAGATA, A
    PALERMO, C
    BIANUCCI, G
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (02) : 151 - 156
  • [8] Salivary and serum β2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjogren syndrome and Sjogren syndrome secondary to systemic lupus erythematosus
    Castro, J
    Jiménez-Alonso, J
    Sabio, JM
    Rivera-Cívico, F
    Martín-Armada, M
    Rodríguez, MA
    Jáimez, L
    Castillo, MJ
    Sánchez-Román, J
    [J]. CLINICA CHIMICA ACTA, 2003, 334 (1-2) : 225 - 231
  • [9] Proteomic profiling of pancreatic cancer for biomarker discovery
    Chen, R
    Pan, S
    Brentnall, TA
    Aebersold, R
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (04) : 523 - 533
  • [10] Diamandis EP, 2005, CLIN CANCER RES, V11, P963